UNSPSC 85811822: Introduction of other antineoplastic into cranial cavity and brain, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into cranial cavity and brain, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0Q305

UNSPSC 85811822 Introduction of other antineoplastic into cranial cavity and brain, percutaneous approach is a Commodity code that shows little relevant recent state and local procurement activity. The recent opportunities tagged under this code are unrelated to the antineoplastic drug delivery procedures its taxonomy name describes—they instead cover virtual urgent care, medical services, PACE operations, orthotic equipment, cancer screening, retinal screening devices, EMS staffing, employee health clinics, occupational health services, histology labs, travel nurse staffing, and behavioral health programs. State and local procurement under this code does not reflect the clinical specialization the UNSPSC nomenclature implies; the mismatch between the code's name and actual buying activity suggests either tagging error or that the code serves as a catch-all classification for disparate health services procurement that lacks category precision.

The recent opportunities span multiple issuing bodies—state health authorities, county health systems, cities, school districts, and public hospital operators—across California, Colorado, Georgia, Florida, Kansas, Missouri, Nevada, Oregon, Texas, Virginia, and the District of Columbia. No clear concentration of activity emerges. Given the mismatch between code definition and recent solicitations, prospective vendors should verify that code assignments in specific opportunities align with their service offerings before pursuing qualification or proposal work.